Ocular Safety Profile of BRAF and MEK Inhibitors
C. Mettler, Dominique Monnet, N. Kramkimel, Jean‐Marc Tréluyer, Luc Mouthon, Antoine P. Brézin, N. Dupin, Marie‐Blanche Valnet‐Rabier, Laurent Chouchana, Benjamin Terrier
Topics & Concepts
MedicinePharmacovigilanceOdds ratioAdverse effectConfidence intervalMEK inhibitorRetrospective cohort studyInternal medicineUveitisOncologyDermatologyOphthalmologyMAPK/ERK pathwayCell biologyBiologyKinaseMelanoma and MAPK PathwaysOcular Oncology and TreatmentsOcular Diseases and Behçet’s Syndrome